In cancer development, the GH-IGF axis, IGF-II, insulin receptors, and hybrid receptors have important roles in the tumour and the tumour microenvironment driving pro-proliferative, angiogenic, and anti-apoptotic signalling for tumour cell survival and growth (5). The gene discussed is GH1; the disease is neoplasm.